Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-03

Clinical Trial Update: The Effects of Methylphenidate on Energy Intake and Energy Expenditure [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating methylphenidate for obesity, specifically its effects on energy intake and energy expenditure. The current trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: Children's Hospital of Eastern Ontario | Conditions: Obesity | Phase 3 | Status: UNKNOWN